D-0825-2021 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

Recall Details

Product Type
Drugs
Report Date
September 29, 2021
Initiation Date
August 27, 2021
Termination Date
October 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15936 bottles

Product Description

Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Reason for Recall

CGMP Deviations

Distribution Pattern

Nationwide.

Code Information

Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022